explore -WSS

explore

author：Wikipedia 2025-09-27 19:28:08 - browse：9928

Obesity conference attendees with a pink and blue Wegovy sign hanging from the ceiling above. -- obesity coverage from STAT — Wegovy, the obesity drug, was inescapable at the ObesityWeek conference in Dallas. Elaine Chen

DALLAS — Here at ObesityWeek, one of the largest conferences on obesity, Novo Nordisk and Eli Lilly are displaying more than a dozen studies that together carry the message: Our blockbuster weight loss treatments will be worth it for society.

But experts point out that much of this company-funded research does not include the cost of the drugs themselves, which sell at more than $10,000 per year in the U.S. and are meant to be taken indefinitely.

The two major pharmaceutical companies have seen interest skyrocket for their GLP-1-based drugs like Ozempic, Wegovy, and Mounjaro, a new generation of medications that can cut substantial amounts of weight. But insurance plans have been slow to grant wide access to obesity treatments, concerned that the vast amount of people eligible to take them, along with their high price, could lead to significant financial strain.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： 3 killed, 8 injured in late

WSS

Chicago flooding is stark reminder of vulnerability of major cities during extreme weather

Trump pressured former Arizona governor to overturn 2020 election results: Sources

Kremlin open to talks over potential prisoner swap involving detained US reporter Evan Gershkovich

Cancer, immunology, HIV research ensnared in fetal tissue politics

US judge blocks portions of new Florida elections law

Ukraine holds disaster drills amid fears Russia could sabotage nuclear power plant

focus

explore

hotspot

Jerome Adams on the need for new antivirals for Covid

6 surprising facts about sugar

Moonlake's readout produced a cash windfall. Risks remain

Diabetes management: Digital health tools fall short, study says

DIEP, the 'gold standard' of breast reconstruction, is under threat

Diabetes management: Digital health tools fall short, study says

New air purifier tech could be key to improving indoor air quality

Brazil's Neymar fined $3.3 million for illegal artificial lake at mansion outside Rio

Novavax promises a turnaround & Lilly roils the obesity market

The Democratic Party promised to overhaul its primaries. Doing that has been anything but simple

focus

Steward Health Care expansion into Malta flopped

Adam's Take: Intra

Kremlin open to talks over potential prisoner swap involving detained US reporter Evan Gershkovich

Medicare Advantage insurers pressure Biden for bigger payments

Some in Scotland's Orkney Islands want to return to Norway after 550 years

1 dead, 9 hurt in July 4th fireworks explosion

knowledge

Wikipedia

hotspot

Wikipedia